l efile GRAPHIC p rint - DO NOT PROCESS I As Filed Data - I DLN: 93493320012086 Return of Organization Exempt From Income Tax OMB No 1545-0047 Form 990 ij Under section 501 ( c), 527, or 4947 ( a)(1) of the Internal Revenue Code (except private foundations) 2 p 1 5 Do not enter social security numbers on this form as it may be made public Department of the ► Treasury ► Information about Form 990 and its instructions is at www IRS gov/form990 Internal Revenue Service A For the 2015 calendar year, or tax y ear beg innin g 01-01-2015 , and ending 12- 31-2015 C Name of organization B Check if applicable D Employer identification number Pharmaceutical Research & Manufacturers F Address change of America 53-0241211 F Name change Doing business as Initial return PHRMA 1 Final E Telephone number return/terminated Number and street (or P 0 box if mail is not delivered to street address) Room/suite 950 F Street No 300 Amended return (202) 835-3400 [Application pending City or town, state or province, country, and ZIP or foreign postal code Wachinntnn DC' 7nnn4 G Gross receipts $ 222,425,689 F Name and address of principal officer H(a) Is this a group return for STEPHEN J UBL subordinates? [ Yes 950 F Street No 300 No Washin g ton, DC 20004 H(b) Are all subordinates I Tax - exempt status EYes [ No F_ 501(c)(3) [ 501( c) ( 6 I (insert no ) [ 4947(a)(1) or [ 527 included? If"No," attach a list (see instructions) 3 Website: www phrma org ► H(c) GrouD exemption number ► L Year of formation 1958 1 M State of legal domicile DE K Form of organization [ Corporation [ Trust [ Association [ Other ► © Summary 1Briefly describe the organization 's mission or most significant activities PHRMA ' S MISSION IS WINNING ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF LIFE-SAVING AND LIFE- ENHANCING NEW MEDICINES FOR PATIENTS BY PHARMACEUTICAL/BIOTECHNOLOGY RESEARCH COMPANIES U ti 7 2 Check this box [ if the organization discontinued its operations or disposed of more than 25% of its net assets L5 ► 3 Number of voting members of the governing body (Part VI, line la) . 3 33 4 Number of independent voting members of the governing body (Part VI, line lb) . 4 32 5 Total number of individuals employed in calendar year 2015 (Part V, line 2a) . 5 224 a 6 Total number of volunteers (estimate if necessary) . 6 3,021 7a Total unrelated business revenue from Part VIII, column (C), line 12 . 7a 0 b Net unrelated business taxable income from Form 990-T, line 34 . 7b 0 Prior Year Current Year 8 Contributions and grants (Part VIII, line 1h) 0 0 9 Program service revenue (Part VIII, line 2g) . 205,359,701 218,370,145 10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) . 3,258,755 1,874,850 11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and Ile) 33,650 6,347 12 Total revenue-add lines 8 through 11 (must equal Part VIII, column (A), line 208,652,106 220,251,342 12) 13 Grants and similar amounts paid (Part IX, column (A), lines 1-3 ) . 20,773,061 18,205,734 14 Benefits paid to or for members (Part IX, column (A), line 4) . 0 0 Salaries, other compensation, employee benefits (Part IX, column (A), lines 15 49 , 391 , 451 58 , 984 , 330 5-10) 16a Professional fundraising fees (Part IX, column (A), line Ile) 0 0 at b Total fundraising expenses (Part IX, column (D), line 25) 0 LLJ ► 17 Other expenses (Part IX, column (A), lines 11a-11d, 1if-24e) . 137,777,125 147,759,205 18 Total expenses Add lines 13-17 (must equal Part IX, column (A), line 25) 207,941,637 224,949,269 19 Revenue less expenses Subtract line 18 from line 12 . 710,469 -4,697,927 8 T Beginning of Current Year End of Year Qm 20 Total assets (Part X, line 16) . 135,545,781 171,355,423 21 Total liabilities (Part X, line 26) . 93,194,442 120,870,792 ZLL 22 Net assets or fund balances Subtract line 21 from line 20 VftfW Si g nature Block Under penalties of perjury, I declare that I have examined this return, 1 my knowledge and belief, it is true, correct, and complete Declaration preparer has any knowledge Signature of officer Sign Here STEPHEN J UBL President & CEO Type or print name and title Print/Type preparer's name Preparer's signature Deborah G Kosnett Deborah G Kosnett Paid Preparer Firm's name ► Tate and Tryon Firm's address 2021 L Street NW Suite 400 Use Only ► Washington, DC 20036 May the IRS discuss this return with the preparer shown above? (see in For Paperwork Reduction Act Notice, see the separate instructions. Form 990 (2015) Page 2 Statement of Program Service Accomplishments Check if Schedule 0 contains a response or note to any line in this Part III E 1 Briefly describe the organization's mission PHRMA's mission is winning advocacy for public policies that encourage the discovery of life-saving and life-enhancing new medicines for patients by pharmaceutical/biotechnoloov research companies 2 Did the organization undertake any significant program services during the year which were not listed on the prior Form 990 or 990-EZ? . EYes F,-,, No If "Yes," describe these new services on Schedule 0 3 Did the organization cease conducting, or make significant changes in how it conducts, any program services? . EYes [No If "Yes," describe these changes on Schedule 0 4 Describe the organization's program service accomplishments for each of its three largest program services, as measured by expenses Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported 4a (Code ) (Expenses $ including grants of $ ) (Revenue $ Public Policy Advocacy PHRMA's mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical/biotechnology research companies PhRMA achieves this mission by working with, and on behalf of, its member companies before governmental and regulatory bodies in the United States and throughout the world in support of pro-patient, pro-innovation policies Specifically, PhRMA advocates for broad patient access to safe and effective medicines through a free market, without government price controls, strong intellectual property incentives, and transparent, efficient regulation and a free flow of information to patients 4b (Code ) (Expenses $ including grants of $ ) (Revenue $ Member Services In representing the country's leading pharmaceutical research and biotechnology companies, PhRMA provides a forum for member companies to participate in discussions of relevant health care issues and to develop consensus positions on matters of public policy advocacy Member companies participate in PhRMA activities through representation on the Board of Directors, Board-level committees and key issue teams, staff work groups, sections, task forces, and subcommittees Member company representatives also regularly communicate with PhRMA staff 4c (Code ) (Expenses $ including grants of $ ) (Revenue $ General Education about Biopharmaceutical industry PhRMA disseminates information about biopharmaceutical companies, their products, and their business, scientific and philanthropic activities through a wide range of channels, including profiles, reports, principles, guidelines, fact sheets, policy papers and other resources These efforts bolster PhRMA's ability to educate and inform members of the general public as well as policymakers, the media, patients and others in the health care community about the biopharmaceutical industry and PhRMA's public policy activities in particular 4d Other program services (Describe in Schedule 0 ) (Expenses $ including grants of $ ) (Revenue $ 4e Total program service expenses 00, Form 990 (2015) Form 990 (2015) Page 3 Checklist of Re q uired Schedules Yes No 1 Is the organization described in section 501(c)(3) or4947(a)(1) (other than a private foundation)? If "Yes," No complete Schedule A . 1 2 Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? . 2 No 3 Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to Yes candidates for public office? If "Yes," complete Schedule C, Part I . 3 4 Section 501(c )( 3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part II 4 5 Is the organization a section 501 (c)(4), 501(c)(5), or 501 (c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? Yes If "Yes, " complete Schedule C, Part III Ij . 5 6 Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? N o If "Yes," complete Schedule D, Part I ^^ . 6 7 Did the organization receive or hold a conservation easement, including easements to preserve open space, No the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part II °^ 7 8 Did the organization maintain collections of works of art, historical treasures, or other similar assets? N o If "Yes," complete Schedule D, Part III .J . 8 9 Did the organization report an amount in Part X, line 21 for escrow or custodial account liability, serve as a custodian for amounts not listed in Part X, or provide credit counseling, debt management, credit repair, or debt No negotiation services?If "Yes," complete Schedule D, Part IV .